Delivery Order SPE2DB22D2009-SPE2DB25FL8NB
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$158K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $64,490.00, is for the supply of 4,568,119,294 units of the Menveo vaccine, a meningococcal conjugate vaccine. The contract is a firm fixed-price delivery order, with a performance period ending on May 5, 2025. AmerisourceBergen, a for-profit organization headquartered in Conshohocken, Pennsylvania, is a significant supplier...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,305.75, is for the delivery of Menveo, a meningococcal vaccine, with a completion date of November 6, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Menveo A-C-Y-W kits, which are vaccines used to prevent meningococcal disease. The contract has a ceiling value of $3,242.82 and a period of performance through May 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO, a vaccine for the prevention of meningococcal disease. The contract has a ceiling value of $13,704.50 and a period of performance through July 30, 2024. It is a firm-fixed-price contract, and there is no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide this critical vaccine...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENVEO vaccine, a meningococcal conjugate vaccine, with a ceiling value of $63,175.00 and a period of performance through February 5, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite...
This is a delivery order awarded to AmerisourceBergen Drug Corporation by the Defense Logistics Agency (DLA) for the supply of Menveo, a meningococcal vaccine. The contract is a firm fixed-price delivery order worth $89,381.65, with a period of performance ending on July 21, 2023. The contract was not set aside for any specific business category. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Menveo, a meningococcal vaccine, with a ceiling value of $14,663.21 and a performance period through May 1, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $260,618.70 and covers the delivery of the vaccine product Menveo (meningococcal groups A, C, Y and W-135 diphtheria conjugate vaccine) in 0.5 mL vials. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 2, 2025. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Menveo, a meningococcal vaccine, with a ceiling value of $6,449.00. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $57,926.88, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has a firm fixed price and is set to be completed by March 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...